NCT03473626View on ClinicalTrials.gov

Phase 1 Food Effect Study for Alicaforsen Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 16, 2018

Primary Completion Date

April 6, 2018

Study Completion Date

April 6, 2018

Conditions
IBD
Interventions
DRUG

Alicaforsen

Alicaforsen tablet

Trial Locations (1)

Unknown

Phase 1 unit, Nottingham

Sponsors
All Listed Sponsors
lead

Atlantic Pharmaceuticals Ltd

INDUSTRY

NCT03473626 - Phase 1 Food Effect Study for Alicaforsen Tablets | Biotech Hunter | Biotech Hunter